Fisun Anna Gennadievna

Bashlakova E.E., Davidovskaya M.V., Evdoshenko E.P., Polyakova K.I., Skoromets A.A., Solodun I.Y., Fisun A.G., Khachanova N.V., Holownia M.A. 4362

Budget impact analysis of teriflunomide (aubagio) proposed inclusion into the programme ‘7 high-cost nosologies’ on the budgets of RF federal and regional public authorities in the field of healthcare to ensure treatment of multiple sclerosis patients

Budget impact analysis of teriflunomide inclusion as first-line disease modifying drugs (DMD) therapy in the List to ensure patients with relapsing-remitting multiple sclerosis (RRMS) within the programme ‘7 high-cost nosologies’ on the budgets of Russian Federation (RF) federal and regional public authorities in the field of health care.

Davidovskaya M.V., Ermolaeva T.N., Kokushkin K.A., Fisun A.G., Holovnja-Voloskova M.J. 3005

Risk sharing agreements - international and russian experience

Clinical Trials and Healthcare Technology Assessment Centre of Moscow Department of Healthcare, Moscow, Russia

Bashlakova E.E., Davidovskaya M.V., Evdoshenko E.P., Polyakova K.I., Skoromets A.A., Solodun I.Y., Fisun A.G., Khachanova N.V., Holownia M.A. 4362

Budget impact analysis of teriflunomide (aubagio) proposed inclusion into the programme ‘7 high-cost nosologies’ on the budgets of RF federal and regional public authorities in the field of healthcare to ensure treatment of multiple sclerosis patients

Davidovskaya M.V., Ermolaeva T.N., Kokushkin K.A., Fisun A.G., Holovnja-Voloskova M.J. 3005

Risk sharing agreements - international and russian experience

Clinical Trials and Healthcare Technology Assessment Centre of Moscow Department of Healthcare, Moscow, Russia